Home
News
Create
Screeners
Insights
Genesis IBRC
81.
70
-4.30
(-5.00%)
Market Cap
₹106.21 Cr
PE Ratio
-477.78
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-5.00%
1M
-9.87%
6M
+249.29%
1Y
+367.66%
5Y
+995.17%
View Company Insights
Latest news about Genesis IBRC
Genesis IBRC India Limited: Promoter Share Transfer of 64.33 Lakh Shares via Inter-se Gift Transaction
3 days ago
Genesis IBRC India Limited announced a promoter shareholding restructuring involving the transfer of 64,33,700 equity shares (49.49% of share capital) from V Varalakshmi to her husband Padmanaban Krishnamoorthy through an inter-se gift transaction. The transfer, scheduled for on or after January 16, 2026, will increase Krishnamoorthy's stake from 12.59% to 62.08% while reducing Varalakshmi's holding from 61.58% to 12.09%. The transaction complies with SEBI exemption regulations for transfers between immediate relatives and maintains the total promoter group shareholding at 74.17%.
V Varalakshmi Acquires 7.37 Lakh Shares in Genesis IBRC India Limited, Promoter Group Holding Rises to 74.17%
4 days ago
Genesis IBRC India Limited Reports Substantial Acquisition of 14.73 Lakh Shares by Promoter Group
4 days ago
Genesis IBRC India Promoters Complete Off-Market Sale of 11.33% Equity Stake
4 days ago
Genesis IBRC India Limited Announces Complete Promoter Exit Through Share Transfer
5 days ago
More news about Genesis IBRC
31
Dec 25
Genesis IBRC India Limited Announces Resignation of Company Secretary Ramakrishna Subray Hegde
Genesis IBRC India Limited announced the resignation of Company Secretary and Compliance Officer Mr. Ramakrishna Subray Hegde, effective December 31, 2025, due to personal reasons. Whole-time Director Mr. Balakrishna Koppula will serve as interim Compliance Officer until a replacement is appointed. The company has completed all required regulatory disclosures under SEBI LODR Regulations to BSE Limited.
22
Nov 25
Genesis IBRC India: Open Offer Completed, Combined Stake Reaches 62.84%
Genesis IBRC India Limited has successfully completed its open offer process, with Mr. Padmanaban Krishnamoorthy acquiring 9,00,200 shares representing 6.92% of voting capital at ₹27 per share. This acquisition, combined with Ms. V Varalakshmi's existing shareholding of 72,69,500 shares (55.92%), brings their total combined stake to 81,69,700 shares or 62.84% of the company's voting capital, as disclosed under SEBI Regulation 29.
Genesis IBRC
81.
70
-
4.
30
(-
5.
00
%)
1 Year Returns:
+367.66%
Industry Peers
Anthem Biosciences
622.10
(-
1.
20
%)
Advanced Enzyme Tech
289.40
(-
0.
28
%)
Genesis IBRC
81.70
(-
5.
00
%)
Vivo Bio Tech
31.78
(+
1.
05
%)
Shree Ganesh Bio-Tech
0.64
(-
1.
54
%)
Genomic Valley Biotech
23.84
(0.0%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation